Dasatrue 70 mg Tablet

Dasatrue 70 mg Tablet contains dasatinib 70 mg, a targeted anticancer medicine used for certain blood cancers. It is an oral tablet taken according to the treatment plan prescribed by the oncologist. Dasatinib works by blocking abnormal tyrosine kinase proteins that promote the growth of leukemia cells.

BUY NOW

Category

Dasatrue 70 mg Tablet is used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. Dasatinib belongs to the tyrosine kinase inhibitor class and blocks abnormal proteins involved in cancer-cell growth and survival. The dose and treatment duration are determined by the treating oncologist according to the patient’s condition and response to therapy. Regular blood tests and medical follow-up may be required during treatment.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 70 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 60 Tablets
Manufacturer Cipla Ltd

Product Also Known As

Dasatrue 70 mg Tablet, Dasatrue 70 Tablet, Dasatrue Dasatinib Tablet, Dasatinib 70 mg Tablet, Dasatinib Leukemia Tablet, Dasatinib Tyrosine Kinase Inhibitor Tablet